Discovering Patterns in Experiences of Patients in Esophageal Cancer Clinical Research

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-05-31

Study Completion Date

2026-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Participation in clinical trials usually favors a particular demographic group. But there is limited research available to explain what study attributes affect the completion of these specific demographic groups.

This study will investigate the safety and efficacy of esophageal cancer treatments. The focus will be on tracking the rates of completion and withdrawal among these individuals.

It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future esophageal cancer research.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Genetic and Environmental Risk Factors Related to Esophageal Cancer

NCT01035398

Esophageal Cancer

ACTIVE_NOT_RECRUITING

Quality of Life Assessment of Patients Receiving Treatment for Esophageal Cancer [Companion to CALGB-9781]

NCT00003381

Esophageal Cancer

TERMINATED

Biological Factors in Predicting Response to Treatment in Patients With Esophageal Cancer or Rectal Cancer

NCT00628368

Colorectal Cancer Esophageal Cancer

COMPLETED NA

Improve the Treatment of Thoracic Esophageal Cancer

NCT01137123

Thoracic Esophageal Squamous Cell Carcinoma

COMPLETED PHASE3

Gefitinib in Treating Patients With Locally Advanced Esophageal Cancer

NCT00100945

Esophageal Cancer

COMPLETED PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Esophageal Cancer

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CROSSOVER

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient is at least 18 years of age
* Diagnosis of esophageal cancer
* Ability to understand a written informed consent document, and the willingness to sign it.

Exclusion Criteria

* Women of childbearing potential without a negative pregnancy test; or women who are lactating.
* Has a serious medical or psychiatric illness likely to interfere with participation in this clinical study.
* Inability to perform regular electronic reporting

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No